AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Antitn Therapy
The first antitn agent that we we had in the 19 nineties was infliximab, which is an intervenous biologic agent. This was followed by alidema, which is subcutaneous. Since then, there were a couple of other a subcutaneous antitn medication, certlsmab, a golemma. And now we have biologics that work in different mechanisms.